These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37371101)

  • 1. Blood and Sputum Eosinophils of COPD Patients Are Differently Polarized than in Asthma.
    Mycroft K; Paplińska-Goryca M; Proboszcz M; Nejman-Gryz P; Krenke R; Górska K
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
    Proboszcz M; Mycroft K; Paplinska-Goryca M; Górska K; Nejman-Gryz P; Jankowski P; Zak N; Krenke R
    COPD; 2019 Dec; 16(5-6):354-361. PubMed ID: 31631716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD.
    Tworek D; Majewski S; Szewczyk K; Kiszałkiewicz J; Kurmanowska Z; Górski P; Brzeziańska-Lasota E; Kuna P; Antczak A
    Respir Res; 2018 Jun; 19(1):108. PubMed ID: 29859068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
    Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
    COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between expressions of myeloperoxidase and eosinophil cationic protein in sputum and clinical features of asthma-chronic obstructive pulmonary disease overlap].
    Yang H; Zhang Y; Zhang J; Pan J; Wang F; Luo X; Chen F
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1215-1221. PubMed ID: 30377121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic chronic obstructive pulmonary disease.
    Fricker M; McDonald VM; Winter NA; Baines KJ; Wark PAB; Simpson JL; Gibson PG
    Allergy; 2021 Jul; 76(7):2079-2089. PubMed ID: 33470427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.
    Negewo NA; McDonald VM; Baines KJ; Wark PA; Simpson JL; Jones PW; Gibson PG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1495-504. PubMed ID: 27445469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sputum IL-25, IL-33 and TSLP, IL-23 and IL-36 in airway obstructive diseases. Reduced levels of IL-36 in eosinophilic phenotype.
    Moermans C; Damas K; Guiot J; Njock MS; Corhay JL; Henket M; Schleich F; Louis R
    Cytokine; 2021 Apr; 140():155421. PubMed ID: 33486314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients.
    Pignatti P; Visca D; Cherubino F; Zampogna E; Lucini E; Saderi L; Sotgiu G; Spanevello A
    Respir Res; 2019 Jul; 20(1):145. PubMed ID: 31291952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Inflammatory Markers in Induced Sputum in Stable Chronic Obstructive Pulmonary Disease Patients with Positive Bronchodilation Tests.
    Guo XX; Deng NS; Chen QH; Yu HY; Ding XH; Hu SP; Nie HX
    Curr Med Sci; 2019 Aug; 39(4):560-567. PubMed ID: 31346991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial.
    Greulich T; Hohlfeld JM; Neuser P; Lueer K; Klemmer A; Schade-Brittinger C; Harnisch S; Garn H; Renz H; Homburg U; Renz J; Kirsten A; Pedersen F; Müller M; Vogelmeier CF; Watz H
    Respir Res; 2018 Apr; 19(1):55. PubMed ID: 29615049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eotaxin in induced sputum of asthmatics: relationship with eosinophils and eosinophil cationic protein in sputum.
    Yamada H; Yamaguchi M; Yamamoto K; Nakajima T; Hirai K; Morita Y; Sano Y; Yamada H
    Allergy; 2000 Apr; 55(4):392-7. PubMed ID: 10782526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar activation state of neutrophils in sputum of asthma patients irrespective of sputum eosinophilia.
    Tak T; Hilvering B; Tesselaar K; Koenderman L
    Clin Exp Immunol; 2015 Nov; 182(2):204-12. PubMed ID: 26148992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
    Xu J; Jiang F; Nayeri F; Zetterström O
    Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlations between chymase activity, levels of tryptase, and eotaxin in the sputum of patients with chronic obstructive pulmonary disease and their clinical implications].
    Zhang XJ; He SH; Xie H; Wei JF; Liu CT
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Oct; 27(10):649-53. PubMed ID: 16200864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Eosinophilic chronic obstructive pulmonary disease: A review].
    Anaev EK
    Ter Arkh; 2023 Oct; 95(8):696-700. PubMed ID: 38158908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD.
    Saha S; Doe C; Mistry V; Siddiqui S; Parker D; Sleeman M; Cohen ES; Brightling CE
    Thorax; 2009 Aug; 64(8):671-6. PubMed ID: 19213775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma.
    Kitaguchi Y; Komatsu Y; Fujimoto K; Hanaoka M; Kubo K
    Int J Chron Obstruct Pulmon Dis; 2012; 7():283-9. PubMed ID: 22589579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood eosinophil count correlates with alveolar damage in emphysema-predominant COPD.
    Nakamura S; Wakahara K; Majima S; Yokoi E; Fukutani E; Otsuki R; Iwano S; Chen-Yoshikawa TF; Kinoshita F; Abe T; Sashio T; Kimura T; Izuhara K; Hashimoto N; Ishii M; Hasegawa Y
    BMC Pulm Med; 2024 Oct; 24(1):510. PubMed ID: 39396940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Inflammatory Mediators in Induced Sputum: Comparative Study in Asthma and COPD.
    Paplińska-Goryca M; Nejman-Gryz P; Górska K; Białek-Gosk K; Hermanowicz-Salamon J; Krenke R
    Adv Exp Med Biol; 2018; 1040():101-112. PubMed ID: 27739024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.